Elixir Capital Ltd (ELIXIR) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Elixir Capital Ltd on NSE and BSE, with an AI summary of each filing.
Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve standalone and consolidated ....
Intimation · 06 Nov 2026, 5:30 am
Elixir Capital Board to Consider Q2 Results on 6th Nov'26 Elixir Capital Limited has scheduled a Board of Directors meeting on 6th Nov'26 to consider and approve the standalone and consolidated un-audited financial results for the quarter and half-year ended 30th Sep'26. The trading window for dealing in company securities, closed since 1st Oct'26, will reopen 48 hours post the declaration of results.
Intimation about change in auditors as approved by members at the 32nd AGM held on 25-Aug-2026
Change in Management · 26 Aug 2026, 12:44 am
Enclosed are the Voting Results alongwith Scrutinizers Report for 32nd AGM held on 25-Aug-2026
Annual General Meeting · 26 Aug 2026, 12:41 am
Enclosed is the proceedings of 25th AGM of the Company held on 25-Aug-2026
Annual General Meeting · 26 Aug 2026, 12:37 am
Enclosed are the unaudited standalone and consolidated financial results for the quarter ended 30-June-2026
Outcome · 13 Aug 2026, 11:49 pm
Elixir Capital Reports Q1FY27 Net Profit of ₹829.61 Lakhs For the quarter ended 30-Jun-26, Elixir Capital reported consolidated results with total income of ₹2,062.09 lakhs and a net profit after tax of ₹829.61 lakhs. This compares to a net profit of ₹368.46 lakhs in Q1FY26. Standalone operations recorded a net loss of ₹1.50 lakhs on total income of ₹3.60 lakhs. The consolidated Basic and Diluted EPS for the quarter was ₹10.56, a significant increase from ₹4.70 YoY. All company activities relate to the Capital Markets segment.
Enclosed are the un-audited financial results (standalone and consolidated) for the quarter ended 30-June-2026
Financial Result · 13 Aug 2026, 11:46 pm
Elixir Capital Reports Unaudited Financial Results for Q1 FY27 Elixir Capital reported a consolidated net profit of ₹613.52 lakhs for the quarter ended 30 Jun'26, compared to a profit of ₹272.60 lakhs in the same quarter last year. Consolidated total income stood at ₹2,062.09 lakhs, up from ₹1,209.24 lakhs YoY. On a standalone basis, the company recorded a net loss of ₹1.50 lakhs against a loss of ₹0.55 lakhs YoY, with total income at ₹3.60 lakhs. The consolidated EPS was ₹10.56, versus ₹4.70 in the prior-year period.
Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve standalone and consolidated ....
Intimation · 13 Aug 2026, 5:30 am
Elixir Capital Board Meeting Scheduled for Q1 Results Elixir Capital Ltd. announced its Board of Directors will meet on 13th Aug'26 to consider and approve the standalone and consolidated un-audited financial results for the quarter ended 30th Jun'26. The trading window for dealing in company securities has been closed from 1st Jul'26 and will reopen 48 hours after the results are declared. This action is pursuant to SEBI's Listing Obligation and Disclosure Requirements regulations.
Enclosed is the Notice of 32nd Annual General Meeting of the Company scheduled to be held on 25-Aug-2026 by Video Conference.
Annual General Meeting · 01 Aug 2026, 11:18 pm
32nd Annual Report for the financial year 2025 - 26
Others (Uncategorized) · 01 Aug 2026, 11:16 pm
Enclosed is an intimation of record date for final dividend
Dividend · 18 Jul 2026, 10:17 pm
Elixir Capital Announces Record Date for FY26 Final Dividend Elixir Capital Ltd. (BSE: 531278) has announced a final dividend of Rs. 1.25 per equity share, equivalent to 12.5%, for the financial year 2025-26. The company has set 18th Aug'26 as the record date to determine shareholder eligibility for the dividend payment. The dividend declaration is associated with its 32nd Annual General Meeting, which is scheduled for 25th Aug'26.
Enclosed is an intimation for allotment of shares on account of exercise of ESOPs and grant of fresh ESOPs
Others (Uncategorized) · 17 Jun 2026, 12:59 am
Elixir Capital Allots Shares and Grants New Employee Stock Options On 16th Jun'26, Elixir Capital allotted 9,289 equity shares of Rs. 10 face value upon the exercise of employee stock options. This increased the paid-up share capital to Rs. 5,81,24,890, comprising 58,12,489 shares. The exercise price was Rs. 10 per share with no premium. Concurrently, the company granted 71,180 new convertible options under its ESOP Scheme 2024 to eligible employees. These options, exercisable at Rs. 10 per share, will vest over a period of one to four years.
The Board of Directors have declared final dividend @ 12.5% i.e. Re. 1.25 per equity share for the financial year 2025 - 2026. The same is subject to approval of members at the 32nd Annual ....
Dividend · 30 May 2026, 3:32 am
Elixir Capital Board Recommends Final Dividend for FY26 Elixir Capital's Board of Directors, at its meeting on 29th May'26, recommended a final dividend for the financial year ended 31st Mar'26. The proposed dividend is 12.5%, equating to Rs. 1.25 per equity share. This recommendation is subject to shareholder approval at the upcoming 32nd Annual General Meeting. The record date for the dividend payment and the date of the AGM will be announced at a later time. This action signals a return of capital to shareholders for FY26.
Declaration of Final Dividend for FY 2025 - 26
Dividend · 30 May 2026, 3:28 am
Elixir Capital Recommends Final Dividend for FY26 Elixir Capital's Board of Directors, in a meeting on 29th May'26, recommended a final dividend of Rs. 1.25 per equity share (12.5%) for the financial year ending 31st Mar'26. The proposed dividend is subject to shareholder approval at the upcoming 32nd Annual General Meeting. The record date for the dividend payment and the date of the AGM will be announced in due course. This action follows the company's disclosure requirements under SEBI regulations.
Outcome of Board Meeting held on 29-May-2026
Change in Management · 30 May 2026, 3:23 am
Elixir Capital Announces FY26 Dividend and Appoints New Statutory Auditor Elixir Capital's board, on 29 May'26, approved its financial results for the quarter and year ended 31 Mar'26. The board recommended a final dividend of Rs. 1.25 per share (12.5%) for FY26, subject to shareholder approval. Key appointments include the change in statutory auditor to M/s. M. Parashar & Co. from the outgoing M/s. JMT & Associates. Additionally, Mrs. Radhika Mehta was re-appointed as Whole Time Director for a five-year term effective 14 Aug'26. Other re-appointments include the secretarial and internal auditors.
Outcome of Board Meeting
Outcome · 30 May 2026, 3:21 am
Elixir Capital Board Declares Dividend, Approves Results and Appoints New Statutory Auditor The board on 29 May'26 approved audited financial results for the quarter and year ended 31 Mar'26. A final dividend of Rs. 1.25 per share (12.5%) was recommended for FY26. Key management changes include the re-appointment of Mrs. Radhika Mehta as Whole Time Director for a 5-year term from 14 Aug'26. Additionally, M/s. M. Parashar & Co., Chartered Accountants were appointed as the new statutory auditors, subject to shareholder approval at the upcoming 32nd Annual General Meeting.
Enclosed is the audited annual financial results for the financial year ended 31-Mar-2026
Financial Result · 30 May 2026, 3:18 am
Elixir Capital Board Declares Dividend and Appoints New Statutory Auditor Elixir Capital's board, on 29-May-26, approved FY26 results and recommended a final dividend of Rs. 1.25 per share (12.5%). Key changes include the appointment of M/s. M. Parashar & Co. as new statutory auditors, replacing the retiring M/s. JMT & Associates, subject to shareholder approval. The board also re-appointed Radhika Mehta as Whole Time Director for a five-year term starting 14-Aug-26. For Q4FY26 (consolidated), the company reported a Net Loss of Rs. 542.59 lakhs versus a loss of Rs. 626.92 lakhs YoY.
Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial Results for ....
Intimation · 29 May 2026, 5:30 am
Elixir Capital Board to Review FY26 Results and Dividend on 29th May'26 Elixir Capital Ltd. has scheduled a Board of Directors meeting on 29th May'26 to consider and approve its audited standalone and consolidated financial results for the quarter and year ended 31st Mar'26. The board will also consider and recommend a dividend for the financial year. The trading window for company securities is closed from 1st Apr'26 and will reopen 48 hours after the results are declared.
INTIMATION OF VESTING OF OPTIONS UNDER ELIXIR CAPITAL EMPLOYEE STOCK OPTION SCHEME -2024 ("SCHEME")
Others (Uncategorized) · 16 May 2026, 10:54 pm
Elixir Capital Announces Vesting of Options Under ESOP Scheme 2024 Elixir Capital announced that 9,289 Employee Stock Options have vested on 16th May'26 under its ESOP Scheme 2024. The scheme originally granted 62,854 options on 16th May'25 and covers a total of 2,000,000 shares. The exercise price is linked to market price at grant, with a minimum floor at the face value of Rs. 10 per share. Vested options are exercisable within two years from the vesting date. A total of 21,759 options under the plan have lapsed to date.
Enclosed is an intimation regarding non-applicability of Large Entity Disclosure
Others (Uncategorized) · 14 Apr 2026, 12:35 am
Elixir Capital Clarifies It Is Not a 'Large Corporate' Elixir Capital Ltd. informed the exchange on 13th Apr'26 that it does not qualify as a 'Large Corporate' as of 31st Mar'26. This classification is based on the criteria set by SEBI's circular (SEBI/HO/DDHS/CIR/P/2018/144) dated 26th Nov'18. Consequently, the company is not subject to the mandatory fund-raising requirements through debt securities applicable to Large Corporates.
Enclosed is an intimation regarding Special Window for transfer of shares held in physical form
Others (Uncategorized) · 03 Apr 2026, 2:55 am
Elixir Capital Opens Window for Physical Share Transfer and Dematerialization Elixir Capital announced a special window from 05 Feb'26 to 04 Feb'27 for the transfer and dematerialization of physical securities. This facility is available to shareholders whose transfer requests, lodged before 01 Apr'19, were previously rejected or returned. To proceed, shareholders must submit original certificates and required documents to the Registrar and Transfer Agent, Bigshare Services. Re-lodged shares will be issued exclusively in dematerialized form. This initiative follows the SEBI Circular dated 30 Jan'26.
Second 100 days campaign ''Saksham Niveshak''
Others (Uncategorized) · 03 Apr 2026, 2:52 am
Elixir Capital Announces 100-Day Campaign for Unclaimed Dividends Elixir Capital launched its second "Saksham Niveshak" 100-day campaign, running from 1st Apr'26 to 9th Jul'26. The initiative urges shareholders to claim unpaid dividends for FY19 through FY25 and update KYC details to prevent the transfer of shares and dividends to the Investor Education and Protection Fund (IEPF). Shareholders with unclaimed dividends, particularly for FY19 (due by 28th Sep'26), are advised to contact the Registrar and Transfer Agent, Bigshare Services, to process their claims and avoid forfeiture.
Enclosed is an announcement related to Elixir Equities Private Limited, subsidiary of the Company.
Others (Uncategorized) · 20 Mar 2026, 10:03 pm
Elixir Capital Subsidiary Settles with SEBI Over Algo Platform Association Elixir Capital Ltd. disclosed on 20th Mar'26 that its subsidiary, Elixir Equities Private Limited, is part of a SEBI Settlement Order. The order, dated 17th Mar'26, falls under the "Settlement Scheme for Association with Certain Algo Platforms, 2025," impacting 111 brokers. Elixir Equities will pay a settlement amount of ₹1,00,000 for alleged violations of SEBI circulars. The company stated the matter does not have any material impact on its financial position or operations beyond the settlement amount.
Enclosed are the Un-audited financial results (standalone and consolidated) for the quarter and nine months ended 31-Dec-2025
Outcome · 14 Feb 2026, 12:43 am
Elixir Capital Q3'26 Consolidated Net Profit Jumps Over 350% YoY Elixir Capital's Q3'26 consolidated net profit surged 356% YoY to ₹402.48 lakhs from ₹88.36 lakhs, driven by a 120% YoY rise in total income to ₹1,371.07 lakhs. Sequentially, net profit increased 136% QoQ. For the nine months ended 31st Dec'25, consolidated net profit declined 46% YoY to ₹845.86 lakhs. The company's standalone operations reported a net loss of ₹0.99 lakhs for Q3'26, a sharp contrast to the consolidated profit, highlighting strong subsidiary performance. Basic EPS for the quarter was ₹6.94.
Enclosed are the un-audited financial results for the quarter and nine months ended 31-Dec-2025
Financial Result · 14 Feb 2026, 12:40 am
Elixir Capital Reports Q3FY26 Consolidated Net Profit of Rs 402.48 Lakhs Elixir Capital reported Q3FY26 consolidated results for the period ended 31 Dec,'25. Net profit rose to Rs 402.48 lakhs, a significant increase from Rs 170.79 lakhs QoQ and Rs 88.36 lakhs YoY. Total income grew to Rs 1,371.07 lakhs, up 22.6% QoQ and 119.1% YoY. Consolidated EPS for the quarter stood at Rs 6.94, compared to Rs 2.94 in the previous quarter and Rs 1.52 in Q3FY25. On a standalone basis, the company posted a net loss of Rs 0.99 lakhs.
Elixir Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve standalone and consolidated ....
Intimation · 13 Feb 2026, 5:30 am
Elixir Capital Board Meeting Scheduled for 13-Feb-26 to Approve Q3FY26 Results Elixir Capital Ltd. has scheduled a Board of Directors meeting for 13-Feb-26 to consider and approve its un-audited standalone and consolidated financial results for the quarter and nine months ended 31-Dec-25. The company also confirmed its trading window has been closed since 01-Jan-26 and will reopen 48 hours after the results are declared.